The clinical implications of selective IgA deficiency

Area of Science:

• Immunology
• Clinical Medicine

Background:

• Selective IgA deficiency (SIgAD) is the most frequent primary immunodeficiency.
• Current definitions based on serum IgA may not fully capture mucosal IgA levels.
• SIgAD can manifest with diverse clinical complications, ranging from infections to autoimmune disorders.

Purpose of the Study:

• To outline the clinical spectrum and diagnostic considerations of SIgAD.
• To highlight potential complications associated with SIgAD.
• To differentiate SIgAD from other forms of IgA deficiency and secondary causes.

Main Methods:

• Review of clinical manifestations and diagnostic criteria for SIgAD.
• Analysis of associated conditions including infections, autoimmune diseases, and malignancies.
• Discussion of differential diagnoses and secondary causes of IgA deficiency.

Main Results:

• SIgAD is linked to increased risks of sinopulmonary and gastrointestinal infections (e.g., Giardia lamblia).
• A wide array of autoimmune diseases, including lupus, thyroid disorders, Type 1 diabetes, and celiac disease, are associated with SIgAD.
• Secondary IgA deficiency can result from medications, infections, or malignancies.

Conclusions:

• Patients with SIgAD require regular monitoring and education regarding potential complications.
• Distinguishing SIgAD from other immunodeficiencies is critical for appropriate management.
• Management may involve prophylactic antibiotics or, rarely, IgG infusions, with a rare risk of anaphylaxis from IgA-containing blood products.